Back to Search

KEDZIE ARRINGTON, MD

MD

Internal Medicine Physician

NPI: 1265285720Individual

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

57.256409(OH)

Research & Publications (14)

Repeat sternotomy in congenital heart surgery: no longer a risk factor.
PMID 18721579·Ann Thorac Surg·2008
8-other
Novel inhibitors of checkpoint kinase 1.
PMID 17854022·ChemMedChem·2007
6-review
Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors.
PMID 17804227·Bioorg Med Chem Lett·2007
8-other
An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis.
PMID 17101792·Mol Cell Biol·2007
8-other
3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6.
PMID 16978863·Bioorg Med Chem Lett·2006
8-other
Encouraging results for the Contegra conduit in the problematic right ventricle-to-pulmonary artery connection.
PMID 16935124·J Thorac Cardiovasc Surg·2006
8-other
Preliminary experience with the MicroMed DeBakey pediatric ventricular assist device.
PMID 16638555·Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu·2006
8-other
Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP.
PMID 16439123·Bioorg Med Chem Lett·2006
8-other
Kinesin spindle protein (KSP) inhibitors. Part 3: synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility.
PMID 16439122·Bioorg Med Chem Lett·2006
7-preclinical
Property-based design of KDR kinase inhibitors.
PMID 15032725·Curr Med Chem·2004
6-review
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding.
PMID 14698157·Bioorg Med Chem Lett·2004
7-preclinical
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors.
PMID 12941314·Bioorg Med Chem Lett·2003
7-preclinical
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics.
PMID 12443771·Bioorg Med Chem Lett·2002
7-preclinical
Darkness filling-in: a neural model of darkness induction.
PMID 11712980·Vision Res·2001
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
CLEVELAND CLINIC 9500 EUCLID AVENUE/JJ24
CLEVELAND, OH 44195

Location

Practice Location

CLEVELAND CLINIC 9500 EUCLID AVENUE/JJ24, CLEVELAND, OH
(216) 444-2200

Quick Facts

NPI
1265285720
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
14

Are you this provider?

Claim Your Profile